Patents by Inventor Regy Lukose

Regy Lukose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11987805
    Abstract: A genetically modified mammalian cell and genetically modified mammalian cell line comprise a recombination sequence inserted in a target locus on a chromosome of the mammalian cell genome, wherein the recombination sequence comprises Bxb1attB sequence from Mycobacterium smegmatis. A transgenic mammalian cell and transgenic mammalian cell line comprise a heterologous nucleic acid stably integrated in a target locus on a chromosome of the mammalian genome, wherein the heterologous nucleic comprises a heterologous gene configured for expression by the transgenic mammalian cell.
    Type: Grant
    Filed: September 24, 2021
    Date of Patent: May 21, 2024
    Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE
    Inventors: William R. Jacobs, Jr., Lawrence Leung, Regy Lukose, Anna Paula de Oliveira
  • Publication number: 20220090146
    Abstract: A genetically modified mammalian cell and genetically modified mammalian cell line comprise a recombination sequence inserted in a target locus on a chromosome of the mammalian cell genome, wherein the recombination sequence comprises Bxb1attB sequence from Mycobacterium smegmatis. A transgenic mammalian cell and transgenic mammalian cell line comprise a heterologous nucleic acid stably integrated in a target locus on a chromosome of the mammalian genome, wherein the heterologous nucleic comprises a heterologous gene configured for expression by the transgenic mammalian cell.
    Type: Application
    Filed: September 24, 2021
    Publication date: March 24, 2022
    Inventors: William R. Jacobs, Jr., Lawrence Leung, Regy Lukose, Anna Paula de Oliveira